Why the study?
Does combined surgical removal and immunochemotherapy improve survival in a patient with metachronous bilateral adrenal metastasis of lung adenocarcinoma?
Does combined surgical removal and immunochemotherapy improve survival in a patient with metachronous bilateral adrenal metastasis of lung adenocarcinoma?
Combined surgical and systemic treatment may extend survival in rare cases of metachronous bilateral adrenal metastasis from non-small cell lung cancer.
May support combined surgery and immunochemotherapy in rare bilateral adrenal metastases from NSCLC; hypothesis-generating and requires prospective validation.
The appropriate surgical indication and combined systemic treatment of a metachronous bilateral adrenal metastasis in non-small cell lung cancer may extend the prognosis.
No takes yet. Share an insight, caveat, or question.
Tomiyama et al. (2022) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: